Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2023-11-15 2023-11-15
Drug Identification Number 02370166 02370166
Brand name PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION
Common or Proper name PIPERACILLIN POWDER FOR INJECTION PIPERACILLIN POWDER FOR INJECTION
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TAZOBACTAM PIPERACILLIN TAZOBACTAM PIPERACILLIN
Strength(s) 0.375G 3G 0.375G 3G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 10
ATC code J01CR J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-03-30 2022-03-30
Remaining supply date 2022-03-30 2022-03-30
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments